InsidersTradesSigma
Browse the full record of transactions filed by Wadlinger Mary E., Executive. Director active across 1 company, notably Forma Therapeutics Holdings, Inc.. Cumulatively, 1 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €40k. Activity tracked since 23 February 2022. The latest transaction was filed on 23 February 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Mary E. Wadlinger is an Executive at Forma Therapeutics Holdings, Inc. She plays a role in the management and strategy of the company, contributing to its development and growth. Her expertise is important for Forma Therapeutics' success.